Michael R. Gionfriddo

Assistant Professor
School of Pharmacy
Graduate School of Pharmaceutical Sciences

Mellon 418B
Phone: 412.396.1926
gionfriddom@duq.edu

Education:

Ph.D., Mayo Clinic, 2016
Pharm.D., Wilkes University, 2011
Bio

Full CV

Dr. Gionfriddo received his Pharm.D. from Wilkes University, then went to the Mayo Clinic in Rochester, Minnesota to complete his Ph.D. in Biomedical Science with a concentration in Clinical and Translation Science.

In his Ph.D., Dr. Gionfriddo worked in the Knowledge and Evaluation Research Unit (Overview - Knowledge and Evaluation Research Unit - Mayo Clinic Research) under Dr. Victor Montori. After his PhD, Dr. Gionfriddo worked in the Center for Pharmacy Innovation and Outcomes (Center for Pharmacy Innovation and Outcomes (geisinger.edu)).

Research

Dr. Gionfriddo's expertise is in evidence synthesis and patient-centered care with a focus on healthcare communication. Dr. Gionfriddo's current work utilizes mixed methods to evaluate and improve the medication use process which includes: evidence generation, guideline development, prescribing, dispensing, and adherence. Dr. Gionfriddo has presented nationally and internally, published several book chapters, and his work has influenced guidelines, been published in high impact journals such as the BMJ, and has been cited over 3,000 times (Google Scholar, h-index 26).

Selected Publications

  1. Lussier ME, Evans HJ, Wright EA, Gionfriddo MR. The impact of community pharmacist involvement on transitions of care: A systematic review and meta-analysis. J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):153-62. PMID: 31427210
  2. Gionfriddo MR, Hagan JB, Rank MA. Why and how to step down chronic asthma drugs. BMJ. 2017 Oct 16;359:j4438. PMID: 29038166
  3. Boehmer KR, Gionfriddo MR, Rodriguez-Gutierrez R, Dabrh AM, Leppin AL, Hargraves I, May CR, Shippee ND, Castaneda-Guarderas A, Palacios CZ, Bora P, Erwin P, Montori VM. Patient capacity and constraints in the experience of chronic disease: a qualitative systematic review and thematic synthesis. BMC Fam Pract. 2016 Sep 1;17:127. PMID: 27585439
  4. Gionfriddo MR, Murad MH, LeBlanc A, Montori VM. GRADE: A framework to evaluate the quality of evidence and facilitate shared decision making. In: Elwyn G, Edwards A, Thompson R, editors. Shared Decision Making in Health Care: Achieving evidence-based patient choice. Oxford University Press; 2016: 136-143 (Book Chapter)
  5. Leppin AL, Gionfriddo MR, Kessler M, Brito JP, Mair FS, Gallacher K, Wang Z, Erwin PJ, Sylvester T, Boehmer K, Ting HH, Murad MH, Shippee ND, Montori VM. Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. JAMA Intern Med. 2014 Jul;174(7):1095-107. PMID: 24820131
Honors
"10 Under 10" Award
2020 Pennsylvania Pharmacists Association

2020

2020 AGING Initiative MCC Scholar 2020
2019 HCSRN Early Career Investigator Award
Health Care Systems Research Network
2019
2018 Award for Innovation in Pharmacy Practice
ASHP Foundation
*for the article: Jones LK, Greskovic G, Grassi DM, Graham J, Sun H,
Gionfriddo MR, Murray MF, Manickam K, Nathanson DC, Wright EA, Evans MA.
Medication therapy disease management: Geisinger's approach to population
health management. Am J Health Syst Pharm. 2017 Sep 15;74(18):1422-35.
PMID: 28887344
2018
Wilkes University Excellence in Pharmaceutical Research Award
Pharmaceutical Sciences Department, Wilkes University, Wilkes-Barre, Pennsylvania
2011
Achieving Independence Competition Winner
Pennsylvania Pharmacists Association
2010
Professional Service

Pennsylvania Pharmacists Association
Editor – Pennsylvania Pharmacist
2021–Present
Pennsylvania Pharmacists Association
Editorial Board Member – Pennsylvania Pharmacist
2017–2020
International Association of Video-Reflexive Ethnographers
Chair
2020–Present
American College of Clinical Pharmacy
Health Outcomes Practice Research Network – Secretary/Treasurer
2020–Present
American Pharmacists Association
Journal of the American Pharmacists Association – Editorial Advisory Board
2018–Present
PLOS ONE
Academic Editor
2017–Present